Microdosing + Meditation for Healthy Adults
(OMM Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to test the feasibility of combining meditation with psilocybin microdosing in healthy adults. The main questions it aims to answer are: 1. Recruitment and retention feasibility 2. Acceptability, Safety and Tolerability 3. Exploratory Measures: 3.1: Explore potential changes in sleep quality and duration, heart rate variability, and other biometric outcomes captured by the Oura Ring (3rd generation). 3.2: Explore potential changes in quality of life scores 3.3: Explore potential differences in altered states of consciousness across groups 3.4: Explore qualitative data collected during sessions and at follow-up to assess satisfaction and receive feedback about the intervention. Every participant will receive the psilocybin microdosing intervention, however, half of the participants will be randomly selected to receive the meditation intervention.
Research Team
Matthew Hicks, ND, MS
Principal Investigator
National University of Natural Medicine
Eligibility Criteria
This trial is for healthy adults interested in combining meditation with psilocybin microdosing. Participants must be willing to use the Oura Ring to monitor biometrics and complete quality of life assessments. Details on specific inclusion or exclusion criteria are not provided.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Meditation (Other)
- Psilocybin (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
National University of Natural Medicine
Lead Sponsor